Acknowledgement for APICES collaboration in SPASSET study

This month, we want to share the acknowledgment that APICES has received in the recent publication of SPASSET Study: Healthcare Resource Utilization and Associated Costs among Patient with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain, published in Cancers, in which APICES has collaborated in study design, setup, project management, monitoring, data management, statistical analysis and medical writing.

This means a great motivation to all APICES team in order to give continuity to the implication we have in every project in which we collaborate. APICES is very proud of the recognition of our work, and we would like to thank AstraZeneca Farmacéutica Spain and Dr Jorge Ginés Rubió for giving us the opportunity to appear in the acknowledgements of the publication and congratulate them and all the investigators for their project success.

This observational, single-center, retrospective study aimed to describe the realworld (RW) healthcare resource utilization (HCRU) among patients with advanced non-small-cell lung cancer (aNSCLC) who received chemotherapy (CT) or immunotherapy (IT) as first and second lines of treatment.

You can find more information in the following link: Healthcare Resource Utilization and Associated Costs among Patients with Advanced NSCL Cancer Receiving Chemotherapy or Immunoterapy in Spain – SPASSET Study